Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

VA Health Systems Research

Go to the VA ORD website
Go to the QUERI website

IIR 99-282 – HSR Study

 
IIR 99-282
Improving Substance Abuse Treatment Aftercare Adherence and Outcome
Steven J Lash, PhD
Salem VA Medical Center, Salem, VA
Salem, VA
Funding Period: August 2001 - January 2005
BACKGROUND/RATIONALE:
Although substance abuse treatment continuing care participation is strongly related to positive treatment outcomes, participation rates are low and few interventions have been developed that improve continuing care adherence and outcome.

OBJECTIVE(S):
The objectives of the study were: 1) to compare the effectiveness of an aftercare intervention consisting of a participation contract, attendance prompts, and attendance reinforcers (CPR) to a standard treatment (STX) on adherence to therapy; and 2) to assess the effects of this intervention on treatment outcome

METHODS:
We recruited 150 veterans from the Salem VAMC’s SARRTP who could participate in aftercare. Our population is similar to those in other VA’s (97% male, 54% Caucasian, 46% minority, 49 years mean age, 44% alcohol dependent only, 56% drug dependent, and 44% with a dual diagnosis). In this randomized clinical trial, treatment adherence and outcome were measured at baseline and 3-, 6- and 12-months after participants entered treatment using interviews, questionnaires, alcohol and drug screens, VA medical records, and therapist ratings. The study design is a repeated measures nested cohort design, with an intervention and a standard care group. The primary outcome, abstinence rate, will be analyzed using a logistic regression model in which the parameters of interest are estimated using Generalized Estimating Equations (GEE).

FINDINGS/RESULTS:
We enrolled 96% of the participants that we had projected to enroll and the follow-up rates were high (80%, 81% and 79% for the 3-, 6- and 12-month interviews, respectively). Final data analysis indicates the duration of aftercare treatment was significantly better in the CPR group. Among participants in the CPR condition, 55% received at least 4 months of treatment (the SUD continuity of care performance measure), compared to 36% of the STX group (p = .02). Similarly, the amount of time in treatment was longer in the CPR than the STX group (188.2 vs. 148.3 days; p = .03). However, no significant increase was found on the frequency of support group participation [i.e., Alcoholics Anonymous (AA) or Narcotics Anonymous (NA); p = .14]. Additionally, compared to STX, the CPR participants were more likely to be abstinent at the 12-month follow-up interview (56% vs. 36%; p. = .03). However, the CPR group did not have a lower percentage of days using alcohol or drugs than the STX group (16% vs. 23%, p = .29). Mediational analyses indicate that the increases in attendance mediated, in part, the impact of CPR on 1-year abstinence rates.

IMPACT:
CPR produced meaningful improvements in adherence to VA aftercare therapy and this translated into improved 1-year abstinence rates. Compared to VA averages, CPR produced significant improvements on the SUD continuity of care performance measure and 1-year abstinence rates. Furthermore, CPR offers a practical and portable means to improve participation and outcome for individuals seeking SUD treatment within the VAMC. The intervention and the study findings have been presented during a national VAMC teleconference on continuity of care in substance use disorder treatment, as well as at several national conferences. The treatment manual and materials have been made available through a VAMC website and have been adopted as part of the treatment program at a number of VAs. Dissemination efforts are ongoing. Currently, a Microsoft Access program is being developed for distribution to automatize the generation of materials and instructions for both therapists and patients. Finally, the CPR intervention has been identified as part of the action plan being developed by the SUD QUERI for enhancing retention in continuing specialty SUD care.


External Links for this Project

Dimensions for VA

Dimensions for VA is a web-based tool available to VA staff that enables detailed searches of published research and research projects.

Learn more about Dimensions for VA.

VA staff not currently on the VA network can access Dimensions by registering for an account using their VA email address.
    Search Dimensions for this project

PUBLICATIONS:

Journal Articles

  1. Lash J, Burden L, Fearer A. Contracting, Prompting and Reinforcing Substance Abuse Treatment Aftercare Adherence. Journal of Drug Addiction, Education and Eradication. 2007 Jul 1; 2(3/4):455-490. [view]
  2. Lash SJ, Stephens RS, Burden JL, Grambow SC, Demarce JM, Jones ME, Lozano BE, Jeffreys AS, Fearer SA, Horner RD. Contracting, prompting, and reinforcing substance use disorder continuing care: a randomized clinical trial. Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors. 2007 Sep 1; 21(3):387-97. [view]
  3. DeMarce JM, Burden JL, Lash SJ, Stephens RS, Grambow SC. Convergent validity of the Timeline Followback for persons with comorbid psychiatric disorders engaged in residential substance use treatment. Addictive Behaviors. 2007 Aug 1; 32(8):1582-92. [view]
  4. Demarce JM, Lash SJ, Stephens RS, Grambow SC, Burden JL. Promoting continuing care adherence among substance abusers with co-occurring psychiatric disorders following residential treatment. Addictive Behaviors. 2008 Sep 1; 33(9):1104-12. [view]
  5. Lash SJ, Burden JL, Monteleone BR, Lehmann LP. Social reinforcement of substance abuse treatment aftercare participation: Impact on outcome. Addictive Behaviors. 2004 Feb 1; 29(2):337-42. [view]
Conference Presentations

  1. Lash S. Behavioral Contracting, Prompting and Reinforcing Substance Abuse Continuing Care. Paper presented at: Association for Behavioral and Cognitive Therapies Annual Convention; 2004 Nov 1; New Orleans, LA. [view]
  2. DeMarce JM, Lash SJ, Stephens RS, Burden JL, Grambow SC. Comorbid Psychiatric Disorders and Substance Abuse: Does Comorbidity Moderate Rates of Aftercare Attendance and Substance Use Outcomes? Poster session presented at: VA Mental Health Annual Conference; 2005 Sep 1; Mesa, AZ. [view]
  3. DeMarce J, Stephens R, Lash S, Grambow SC. Comorbid Psychiatric Disorders with Substance Use Disorders: Does Comorbidity Moderate Rates of Aftercare Attendance and Substance Use Outcomes? Paper presented at: Association for Behavioral and Cognitive Therapies Annual Convention; 2004 Nov 1; New Orleans, LA. [view]
  4. Lash S, Stephens R, Burden J, Grambow S, Horner R, Jeffreys A, Horner RD. Contracting, Prompting, and Reinforcing Substance Abuse Continuing Care: Impact on Treatment Adherence and Outcome. Paper presented at: Association for Behavioral and Cognitive Therapies Annual Convention; 2004 Nov 1; New Orleans, LA. [view]
  5. DeMarce JM, Burden JL, Lash SJ, Stephens RS, Bruke R, Parker JD, Grambow SC. Convergent Validity of the Timeline Followback for Veterans Diagnosed with Co-occurring Substance Use and Psychiatric Disorders via the Structured Clinical Interview for DSM-IV. Poster session presented at: Association for the Advancement of Behavior Therapy Annual Convention; 2007 Nov 1; Philadelphia, PA. [view]
  6. DeMarce JM, Voss Horrell S, Lash SJ, Grambow SC. Impact of ethnicity on outcomes in substance use disorder continuing care. Poster session presented at: VA Mental Health Annual Conference; 2010 Jul 1; Baltimore, MD. [view]
  7. Lash S, Stephens R, Burden J, Grambow S, Horner R, Jeffreys A. Improving Performance on the SUD Continuity of Care Performance Measure: A Clinical Trial of a Behavioral Aftercare Adherence Intervention. Paper presented at: VA Best Practices in Mental Healthcare Systems Annual Conference; 2004 Jun 1; Boston, MA. [view]
  8. Lash SJ, Stephens RS, Burden JL, Grambow SC, Horner RD, Fearer SA. Improving Substance Abuse Treatment Aftercare Adherence and Outcome. Paper presented at: VA HSR&D National Meeting; 2005 Feb 1; Baltimore, MD. [view]
  9. Lash SJ, Roopa S, Fearer SA. Predictive ability of the Treatment Motivation Questionnaire in Substance Abuse Treatment. Poster session presented at: American Society of Clinical Psychopharmacology New Clinical Drug Evaluation Unit Scientific Meeting; 2011 Jun 1; Boca Raton, FL. [view]
  10. Roopa S, Lash SJ, Fearer SA. Predictive ability of the Treatment Motivation Questionnaire in Substance Abuse Treatment. Poster session presented at: American Psychiatric Association Annual Meeting; 2011 May 1; Honolulu, HI. [view]
  11. Burden J, Lash S, Stephens R, Fearer S, DeMarce J. Staying Engaged: The Role of Treatment Motivation in Mediating Aftercare Adherence and Substance Use Outcomes. Paper presented at: Association for Behavioral and Cognitive Therapies Annual Convention; 2004 Nov 1; New Orleans, LA. [view]
  12. Jones M, Walker N, Lozano B, Stephens R, Lash S. Therapeutic Alliance and Outpatient Substance Abuse Aftercare: Mediation Between Intervention and Treatment Outcome? Paper presented at: Association for Behavioral and Cognitive Therapies Annual Convention; 2004 Nov 1; New Orleans, LA. [view]
  13. DeMarce JM, Lash SJ, Parker JD, Burden JL, Stephens RS, Burke R, Grambow SC. Treatment Outcomes of Substance Abusers with and without Co-occurring Psychiatric Disorders Diagnosed Via the Structured Clinical Interview for DSM-IV. Poster session presented at: VA Mental Health Annual Conference; 2009 Jul 1; Washington, DC. [view]
  14. DeMarce JM, Burden JL, Lash SJ, Stephens RS, Grambow SC. Validity of the Timeline Follow-back for Inpatients with Co-morbid Psychiatric Disorders. Poster session presented at: Association for the Advancement of Behavior Therapy Annual Convention; 2006 Nov 1; Chicago, IL. [view]


DRA: Substance Use Disorders, Health Systems
DRE: Epidemiology
Keywords: Behavior (patient)
MeSH Terms: none

Questions about the HSR website? Email the Web Team

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.